Literature DB >> 31416403

Comparison of bleaching protocols utilizing hematoxylin and eosin stain and immunohistochemical proliferation marker MCM3 in pigmented melanomas.

Tierney Jordan1, Destinee Williams1, Sheila Criswell1, Yongfu Wang2.   

Abstract

Melanomas represent the malignant transformation of melanocytes, cells found primarily in the skin to protect epithelium and underlying connective tissues from harmful effects of ultraviolet light. Melanomas vary greatly in morphology and may continue to produce melanin markedly, mildly, or not at all. Performing and evaluating hematoxylin and eosin stains as well as immunohistochemical stains on pigmented melanomas has been a long-standing challenge due to the obscuring pigment. Protocols for removing melanin to reveal cellular morphology have been used successfully for years, but coupling these protocols with stains for immunohistochemistry represents an added challenge. In this study, the investigators evaluated results of various melanin bleaching protocols on tissue morphology, completeness of melanin removal, and immunohistochemistry staining quality. It was found that 1% formamide in 3% H2O2 under bright light without heating outperformed other tested protocols.

Entities:  

Keywords:  Melanoma; bleach; hydrogen peroxide; melanin

Mesh:

Substances:

Year:  2019        PMID: 31416403     DOI: 10.1080/01478885.2019.1649886

Source DB:  PubMed          Journal:  J Histotechnol        ISSN: 0147-8885            Impact factor:   0.714


  3 in total

1.  Step-by-step preparation of mouse eye sections for routine histology, immunofluorescence, and RNA in situ hybridization multiplexing.

Authors:  Ji Pang; Nancy Thomas; Dai Tsuchiya; Tari Parmely; Deyue Yan; Ting Xie; Yongfu Wang
Journal:  STAR Protoc       Date:  2021-11-05

2.  A Fast and Automated Melanin-bleaching Method for Histopathologic Evaluation of Pigmented Melanoma Tissues.

Authors:  Filippo Ugolini; Gianna Baroni; Romina Nassini; Francesco De Logu; Daniela Massi
Journal:  Appl Immunohistochem Mol Morphol       Date:  2022-04-01

3.  Bright-Field Multiplex Immunohistochemistry Assay for Tumor Microenvironment Evaluation in Melanoma Tissues.

Authors:  Filippo Ugolini; Elisa Pasqualini; Sara Simi; Gianna Baroni; Daniela Massi
Journal:  Cancers (Basel)       Date:  2022-07-28       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.